SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-003474
Filing Date
2024-01-23
Accepted
2024-01-23 17:00:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 4471165
2 form424b3_001.jpg GRAPHIC 4999
3 form424b3_002.jpg GRAPHIC 112921
4 form424b3_003.jpg GRAPHIC 7497
  Complete submission text file 0001493152-24-003474.txt   4638905
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274885 | Film No.: 24553297
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)